GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $250,000 | -11.7% | 6,800 | -9.6% | 0.02% | -23.1% |
| Q3 2020 | $283,000 | -11.3% | 7,523 | -3.8% | 0.03% | -10.3% |
| Q2 2020 | $319,000 | -66.1% | 7,823 | -68.5% | 0.03% | -81.2% |
| Q1 2020 | $941,000 | +77.5% | 24,823 | +120.2% | 0.15% | +81.2% |
| Q4 2019 | $530,000 | -53.3% | 11,273 | -57.7% | 0.08% | -49.4% |
| Q3 2019 | $1,136,000 | 0.0% | 26,623 | -6.2% | 0.17% | 0.0% |
| Q2 2019 | $1,136,000 | -15.3% | 28,394 | -11.5% | 0.17% | -7.7% |
| Q1 2019 | $1,341,000 | +18.8% | 32,090 | +8.6% | 0.18% | +6.4% |
| Q4 2018 | $1,129,000 | -1.1% | 29,541 | +3.9% | 0.17% | +56.9% |
| Q3 2018 | $1,142,000 | +0.6% | 28,433 | +0.9% | 0.11% | -32.7% |
| Q2 2018 | $1,135,000 | +430.4% | 28,168 | +406.6% | 0.16% | +362.9% |
| Q4 2016 | $214,000 | -18.0% | 5,560 | -8.2% | 0.04% | -12.5% |
| Q3 2016 | $261,000 | +19.2% | 6,057 | +11.4% | 0.04% | +14.3% |
| Q4 2015 | $219,000 | +7.9% | 5,436 | +2.8% | 0.04% | +9.4% |
| Q3 2015 | $203,000 | – | 5,286 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |